PRAX - CIK 0001689548
The table below shows Praxis Precision Medicines, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$249.07M | -$131.76M | -$111.14M | -$185.04M | -$124.55M | -$52.62M |
| Capital expenditure | $56.00K | $0.00 | $50.00K | $444.00K | $1.05M | $0.00 |
| Investing cash flow | -$311.15M | -$248.49M | $38.95M | $96.89M | -$140.52M | $0.00 |
| Dividends paid | - | - | - | - | - |
Praxis Precision Medicines, Inc. reported operating cash flow of -$249.07M for fiscal year 2025. That is down 89.0% from -$131.76M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$33.42M (FY 2019) to -$249.07M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $702.17M | $514.32M | $91.87M | $10.46M | $107.59M | $304.42M |